Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties
Authors:
- 19 November 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (4) , 1828-1847
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Recent advances towards the discovery of ORL-1 receptor agonists and antagonistsExpert Opinion on Therapeutic Patents, 2005
- Peptide and nonpeptide ligands for the nociceptin/orphanin FQ receptor ORL1: Research tools and potential therapeutic agentsLife Sciences, 2003
- Non Peptidic Ligands at the Opioid Receptor Like-1 (ORL-1)Mini-Reviews in Medicinal Chemistry, 2001
- Lead generation and lead optimisation approaches in the discovery of selective, non-peptide ORL-1 receptor agonists and antagonistsExpert Opinion on Therapeutic Patents, 2001
- In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonistEuropean Journal of Pharmacology, 2000
- The potential therapeutic value of nociceptin receptor agonists and antagonistsExpert Opinion on Therapeutic Patents, 2000
- A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397European Journal of Pharmacology, 2000
- Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist: 1-[(3R,4R)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2H-benzimidazol-2-one (J-113397)Journal of Medicinal Chemistry, 1999
- Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled ReceptorScience, 1995
- Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptorNature, 1995